Sponsored by: WuXi AppTecIn this exciting new webinar, sponsored by Ultivue, we will explore the intratumoral administration of autologous, non-manipulated myeloid dendritic cells in combination with immune checkpoint inhibitors in patients with advanced solid tumors and in combination with the oncolytic virus talimogene laherparepvec (Imlygic®) in patients with advanced melanoma in phase I clinical trials.
Sponsored by: WuXi AppTecIn this GEN webinar, sponsored by WuXi AppTec, we will review the challenges of utilizing AAV, as well as discuss in detail the recent progress and outstanding questions in AAV-based gene therapy.
This GEN webinar, sponsored by Invitria, will discuss the real contamination risks described in a recent study and how companies are rising to this challenge through a better selection of components and excipients.
Sponsored by: Thermo Fisher ScientificIn this GEN webinar, sponsored by Thermo Fisher Scientific, our presenters will highlight upstream and downstream solutions across the AAV production workflows.
In this GEN webinar, sponsored by Bruker, our esteemed presenter Dr. Roman Fischer from the University of Oxford, will showcase the application andlimitations of high-throughput timsTOF Pro mass spectrometry on large scale clinicalsample sets in order to stratify patients and contribute to a multi-omics blood atlasof COVID-19 patients, and the combination of laser capture microdissection withproteomics methods for the 3D characterization of large biological macrostructuressuch as organs or tumors.
Sponsored by: 3DS Dassault Systemes REGISTER NOW Broadcast Date: February 5, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Antibody-drug conjugates (ADCs) were initially developed to provide a selective targeting...
Sponsor: Dassault SystèmesGEN's on demand webinar, sponsored by Dassault Systèmes, discusses the current state of The Living Brain Project and how it is being applied to traumatic brain injury, neuromodulation, neurodegenerative disease progression, and drug delivery through cerebrospinal fluid.
Sponsored by: AgilentThis presentation will show how low concentrated samples, as well as libraries prepared for long read sequencing benefit from QC, performed with the Femto Pulse.
Sponsor: CisbioWhile the importance of ligand-receptor binding kinetics on drug action is becoming well established, focus to date has been almost entirely on the role of the dissociation constant on drug efficacy and duration of action. The association rate constant, in contrast, has been largely overlooked, with many investigators still considering it diffusion-limited and equivalent across a compound series. This GEN webinar aims to remedy that by turning the spotlight onto the undervalued and oft-ignored association rate constant.
Sponsor: Bio-techneIn this GEN webinar, we will hear from Danica Stanimirovic MD, PhD, and Danica Stanimirovic MD, PhD, wto leading scientists who will describe their current antibody engineering research projects and the therapeutic potential they hold.
Sponsor: Advanced Cell DiagnosticsIn this GEN webinar sponsored by Advanced Cell Diagnostics, we will hear about new PDAC research showing that the cytokine leukemia inhibitory factor (LIF) key paracrine factor from activated pancreatic stellate cells acting on cancer cells.
Sponsor: NanotemperIn this GEN webinar, we will learn from Dr. Daniel Lauster, who, when faced with many of the challenges described above, utilized MicroScale Thermophoresis (MST) to measure the interaction between more than 100 novel non-toxic multivalent nanoparticle-conjugates and intact IAV in solution with as little as nanomoles of nanoparticles. Additionally, we will hear from Dr. Matthias Molnar how MST is becoming scientists’ first choice for the characterization of molecular interactions thanks to its flexible throughput, low sample consumption, and measurements in solution or in close to native conditions.
Sponsor: Advanced Cell DiagnosticsIn this GEN webinar, we will hear about recent findings implicating the Hippo effector, Yap, as a driver of a novel damaged-induced intestinal stem cell population.
Sponsor: N of OneIn this roundtable, our panelists will discuss assessing the validity of biomarkers to inform drug development and potential combination therapies. Key considerations include predictive testing of biomarkers, analytical methods, drug-diagnostic co-development and potential reimbursement considerations.